705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)

• Andrew Mackinnon,
• Jason Chen,
• Natalija Sotirovska,
• Susanne Steggerda,
• Francesco Parlati,
• Tony Huang,
• Weiqun Li,
• Winter Zhang,
• Yong Ma,
• Deepthi Bhupathi

Affiliations

Andrew Mackinnon

Calithera Biosciences, Inc., South San Francisco, CA, USA

Jason Chen

Aff95 Calithera Biosciences South San Francisco CA USA

Natalija Sotirovska

Aff95 Calithera Biosciences South San Francisco CA USA

Susanne Steggerda

Aff95 Calithera Biosciences South San Francisco CA USA

Francesco Parlati

Aff95 Calithera Biosciences South San Francisco CA USA

Tony Huang

Aff96 Calithera Biosciences South San Francisco CA USA

Weiqun Li

Aff96 Calithera Biosciences South San Francisco CA USA

Winter Zhang

Aff96 Calithera Biosciences South San Francisco CA USA

Yong Ma

China Health Insurance Research Association, Beijing, China

Deepthi Bhupathi

Calithera Biosciences, Inc., South San Francisco, CA, USA